Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint

Go back to Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint
BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 13.48 -0.18 (1.32%)
Previous Close $13.66    52 Week High $5.58 
Open $13.50    52 Week Low $3.60 
Day High $13.53    P/E N/A 
Day Low $13.28    EPS $0.00 
Volume 10,644,641       

SANOFI (NASDAQ: SNY) Delayed: 40.23 +0.03 (0.07%)
Previous Close $40.20    52 Week High $44.76 
Open $40.18    52 Week Low $36.81 
Day High $40.27    P/E N/A 
Day Low $39.58    EPS $0.00 
Volume 2,996,856       

(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $17.59    P/E N/A 
Day Low $17.59    EPS $ 
Volume 15,962       

(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $17.59    P/E N/A 
Day Low $17.59    EPS $ 
Volume 15,962       

(AMEX: ZLDPY) Delayed: 8.67 --0 (-0%)
Previous Close $8.67    52 Week High $ 
Open $8.67    52 Week Low $ 
Day High $8.67    P/E N/A 
Day Low $8.67    EPS $ 
Volume 21